查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404718

聚合物生物材料市場規模、佔有率、趨勢分析報告：按產品、按應用、按地區、細分市場預測，2024-2030

Polymeric Biomaterials Market Size, Share & Trends Analysis Report By Product (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polyurethane), By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10個工作天內

價格

高分子生物材料市場成長與趨勢：

Grand View Research的最新報告顯示，到2030年，全球高分子生物材料市場規模預計將達到1,488.7億美元。

預計2024年至2030年市場將以16.54%的複合年成長率擴張。這種成長是由產品創新的增加、聚合生物材料在組織工程中應用的擴大以及外科手術中對聚合生物材料的需求不斷成長所推動的。

再生醫學領域對聚合物生物材料的需求不斷成長正在推動市場成長。此外，聚乳酸乙醇酸（PLGA）、聚乙二醇（PEG）和聚己內酯（PCL）等合成聚合物廣泛用於細胞遞送應用。同樣，也研究了包含無機結構的複合水凝膠其微創細胞引入用於組織修復目的的潛力。

由於多次更嚴格的封鎖、供應鏈業務中斷以及臨床研究活動減少，COVID-19 大流行對市場產生了負面影響。儘管存在負面影響，但由於擴大採用聚合生物材料來設計新的 COVID-19 治療策略，因此從長遠來看，市場預計將出現強勁的成長前景。例如，2021 年 4 月發表在《Emergent Materials Journal》上的一篇論文稱，正在研究生物材料來控制藥物輸送，例如白細胞介素-6 (IL-6) 抑制劑，用於治療COVID-19。我做到了。因此，由於對 COVID-19 新型療法的需求不斷增加，預計未來幾年市場將顯著成長。

此外，行業主要企業正在採取各種策略，如收購、聯盟、合作夥伴關係、業務擴張和新產品發布，以鞏固其市場地位並擴大基本客群。例如，2023年1月，微創科學公司的Firehawk Liberty雷帕黴素靶點洗脫冠狀動脈支架系統在俄羅斯取得上市核准。此次核准預計將擴大該公司的地域影響力。此外，2022年7月，Corbion與STENTiT和Vivolta合作開發再生支架，用於臨床使用和治療嚴重肢體缺血患者。領先公司擴大採用策略，預計將推動 2023 年至 2030 年的市場成長。

與其他生物材料相比，聚合物生物材料缺乏機械強度和穩定性。因此，它的使用可能會限制在需要高強度、耐用性和承載能力能力的應用中。然而，主要參與者增加對聚合生物材料技術進步的投資預計將在預測期內減少這項挑戰。

聚合物生物材料市場報告亮點

  • 以產品來看，聚乳酸（PLA）細分市場佔據最大市場佔有率，到2023年將達到20.85%。此細分市場的成長歸因於多種 PLA 混合物在藥物傳輸、植入和縫線製造以及組織工程應用領域的廣泛應用。
  • 從應用來看，整形外科領域在2023年佔據市場主導地位，佔有率為23.49%。這一領域的成長是由於整形外科疾病的日益流行，這反過來又促使科學家利用聚合生物材料發現新的、更有效的治療方法。
  • 由於整形外科損傷和整容手術數量不斷增加以及對永續生物材料的需求，北美在 2023 年佔據最大的市場佔有率，達到 38.49%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 附隨市場前景
  • 市場趨勢及展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 營商環境分析
    • PESTEL分析
    • 波特五力分析
  • COVID-19 影響分析

第4章 產品經營分析

  • 高分子生物材料市場：產品波動分析
  • 聚乳酸（PLA）
    • 世界聚乳酸
  • 聚乙醇酸 (PGA)
    • 世界聚乙醇酸
  • 聚氨酯
    • 2018-2030年全球聚氨酯市場
  • 聚四氟乙烯 (PTFE) 和膨體聚四氟乙烯 (ePTFE)
    • 世界各地的聚四氟乙烯
  • 聚芳醚醚酮 (PEEK)
    • 世界聚烯丙基醚醚酮
  • 聚二氧環己酮 (Pdo)
    • 世界聚二噁烷酮
  • 其他
    • 2018-2030年全球其他產品市場

第5章 應用業務分析

  • 高分子生物材料市場：應用變化分析
  • 心血管
    • 全球心血管市場，2018-2030
    • 生物可吸收支架
    • 血管移植物
    • 感應器
    • 導管導引線
    • 植入式心臟整流去顫器
    • 起搏器
    • 其他
  • 牙科
    • 全球牙科市場，2018-2030
    • 組織再生材料
    • 人工植牙
    • 骨移植和人工骨骼替代物
    • 牙膜
    • 牙科用縫合線
    • 其他
  • 整形外科
    • 2018-2030年全球整形外科市場
    • 臉部皺紋治療
    • 軟組織填充材
    • 顱顏手術
    • 生物工程皮膚
    • 週邊神經修復
    • 去細胞真皮基質
    • 其他
  • 神經病學
    • 全球神經病學市場，2018-2030
    • 神經幹細胞封裝
    • 分流系統
    • 水凝膠支架
    • 皮質神經假體
    • 其他
  • 整形外科
    • 全球整形外科市場，2018-2030
    • 關節重建高分子生物材料
    • 組織固定產品
    • 生物性骨材
    • 關節內粘稠補充療法
    • 脊椎生物材料
    • 其他
  • 其他用途
    • 全球其他應用市場，2018-2030

第6章 區域業務分析

  • 北美洲
    • 2018-2030年北美聚合物生物材料市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030年歐洲聚合物生物材料市場估計與預測
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區聚合物生物材料市場預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2018-2030年拉丁美洲聚合物生物材料市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018-2030年中東和非洲聚合物生物材料市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章競爭形勢

  • 參與企業概況
    • MEDTRONIC
    • STRYKER CORPORATION
    • BASF SE
    • EVONIK INDUSTRIES AG
    • DSM
    • BEZWADA BIOMEDICAL, LLC
    • CORBION
    • VICTREX PLC（INVIBIO LTD.）
    • INTERNATIONAL POLYMER ENGINEERING
    • COVALON TECHNOLOGIES LTD.
    • ABBOTT
    • ELIXIR MEDICAL
    • REVA MEDICAL, LLC
    • MERIL LIFE SCIENCES PVT. LTD.
    • MICROPORT SCIENTIFIC CORPORATION
  • 參與企業
    • 2023年高分子生物材料市場佔有率分析
  • 策略規劃
    • 擴張
    • 獲得
    • 協作與夥伴關係
    • 產品發表會
    • 其他

第8章分析師的觀點

Product Code: GVR-4-68040-088-6

Polymeric Biomaterials Market Growth & Trends:

The global polymeric biomaterials market size is anticipated to reach USD 148.87 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.54% from 2024 to 2030. The growth is attributed to the rising product innovations, increasing applications of polymeric biomaterials in tissue engineering, and the growing need for polymeric biomaterials in surgical procedures.

Increasing demand for polymeric biomaterials in the field of regenerative medicine is fueling market growth. Polymeric biomaterials such as injectable hydrogels act as a promising solution for the rising demand for minimally invasive cell delivery systems owing to the ability to undergo a flexible sol-gel transition and adaptively fill defects, enabling minimally invasive interventions.Furthermore, several synthetic polymers, such as Poly (lactic-co-glycolic acid) (PLGA), Polyethylene Glycol (PEG), and Polycaprolactone (PCL), are widely utilized in cell delivery applications. Similarly, composite hydrogels incorporating inorganic constructs have also been investigated for their potential in facilitating minimally invasive cell delivery for tissue repair purposes.

The COVID-19 pandemic adversely affected the market in due to several lockdown strictures, hindrances in supply chain operations, and decreased clinical research activities.Despite the negative impact, the market is expected to witness strong growth prospects in the long term due to the increasing adoption of polymeric biomaterials for devising new therapeutic strategies for COVID-19 treatment. For instance, according to an article published in the Emergent Materials Journal in April 2021, biomaterial substances were studied for the controlled delivery of drugs, such as interleukin 6 (IL-6) inhibitors, for COVID-19 treatment. As a result, with the increasing demand for novel therapeutics for COVID-19, the market is expected to witness significant growth in the coming years.

Furthermore, key players in the industry are adopting various strategies such as acquisitions, collaborations, partnerships, expansions and new product launches to strengthen their market position and expand their customer base. For instance, in January 2023, MicroPort Scientific Corporation received marketing approval for its Firehawk Liberty Rapamycin Target Eluting Coronary Stent System in Russia. This approval is anticipated to expand the company's geographical presence. Moreover, in July 2022, Corbion collaborated with STENTiT and Vivolta for the development of a regenerative stent for clinical use and treatment of patients suffering from critical limb ischemia. This increasing adoption of strategies by major companies are anticipated to drive market growth from 2023 to 2030.

Polymeric biomaterials lack mechanical strength and stability as compared to other biomaterial substances. Hence, for applications with high strength, durability, or load-bearing capabilities, it may find limited usage. However, increasing investment in the technological advancement of polymeric biomaterials by major players is anticipated to mitigate this challenge over the forecast period.

Polymeric Biomaterials Market Report Highlights:

  • Based on the product, the Polylactic Acid (PLA) segment held the largest market share of 20.85% in 2023. The segment growth is attributed to the wide application of several types of PLA blends in the field of drug delivery, manufacturing of implants & sutures, and tissue engineering applications
  • Based on the application, the orthopedic segment dominated the market with a share of 23.49% in 2023. The segment growth is attributed to the growing incidence of orthopedic diseases, which in turn, is encouraging scientists to discover novel and more effective treatment options using polymeric biomaterials
  • North America held the largest market share of 38.49% in 2023, owing to a rise in the number of surgical procedures for orthopedic injuries and cosmetic surgeries and the need for sustainable biomaterials

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Market Definitions
    • 1.2.1 Information Analysis
    • 1.2.2 Market Formulation & Data Visualization
    • 1.2.3 Data Validation & Publishing
  • 1.3 Research Assumptions
  • 1.4 Information Procurement
    • 1.4.1 Primary Research:
  • 1.5 Information or Data Analysis
  • 1.6 Market Formulation & Validation
  • 1.7 Market Model
  • 1.8 Global Market: CAGR Calculation
  • 1.9 Objectives

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Market Trends & Outlook
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Rising Demand For Polymeric Biomaterials For Minimally Invasive Applications
      • 3.3.1.2 Advancements In Biomaterials Technologies
      • 3.3.1.3 Expansion In The Scope Of Applications For Biomaterials
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 High expenses associated with the development and commercialization of biomaterials
      • 3.3.2.2 Problems related to mechanical strength and stability of polymeric biomaterials
  • 3.4 Business Environment Analysis
    • 3.4.1 Pestel Analysis
    • 3.4.2 Porter's Five Forces Analysis
  • 3.5 COVID-19 Impact Analysis

Chapter 4 Product Business Analysis

  • 4.1 Polymeric Biomaterials Market: Product Movement Analysis
  • 4.2 Polylactic Acid (PLA)
    • 4.2.1 Global Polylactic Acid (PLA) Market, 2018 - 2030 (USD Million)
  • 4.3 Polyglycolic Acid (PGA)
    • 4.3.1 Global Polyglycolic Acid (PGA) Market, 2018 - 2030 (USD Million)
  • 4.4 Polyurethanes
    • 4.4.1 Global Polyurethanes Market, 2018 - 2030 (USD Million)
  • 4.5 Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
    • 4.5.1 Global Polytetrafluoroethylene (Ptfe) & Expanded Polytetrafluoroethylene (Eptfe) Market, 2018 - 2030 (USD Million)
  • 4.6 Polyaryletheretherketone (PEEK)
    • 4.6.1 Global Polyaryletheretherketone (PEEK) Market, 2018 - 2030 (USD Million)
  • 4.7 Polydioxanone (Pdo)
    • 4.7.1 Global Polydioxanone (Pdo) Market, 2018 - 2030 (USD Million)
  • 4.8 Others
    • 4.8.1 Global Other Products Market, 2018 - 2030 (USD Million)

Chapter 5 Application Business Analysis

  • 5.1 Polymeric Biomaterials Market: Application Movement Analysis
  • 5.2 Cardiovascular
    • 5.2.1 Global Cardiovascular Market, 2018 - 2030 (USD Million)
    • 5.2.2 Bioresorbable Stents
      • 5.2.2.1 Global Bioresorbable Stents Market, 2018 - 2030 (USD Million)
    • 5.2.3 Vascular Grafts
      • 5.2.3.1 Global Vascular Grafts Market, 2018 - 2030 (USD Million)
    • 5.2.4 Sensors
      • 5.2.4.1 Global Sensors Market, 2018 - 2030 (USD Million)
    • 5.2.5 Guidewires
      • 5.2.5.1 Global Guidewires Market, 2018 - 2030 (USD Million)
    • 5.2.6 Implantable Cardiac Defibrillators
      • 5.2.6.1 Global Implantable Cardiac Defibrillators Market, 2018 - 2030 (USD Million)
    • 5.2.7 Pacemakers
      • 5.2.7.1 Global Pacemakers Market, 2018 - 2030 (USD Million)
    • 5.2.8 Others
      • 5.2.8.1 Global Others Market, 2018 - 2030 (USD Million)
  • 5.3 Dental
    • 5.3.1 Global Dental Market, 2018 - 2030 (USD Million)
    • 5.3.2 Tissue Regeneration Materials
      • 5.3.2.1 Global Tissue Regeneration Market, 2018 - 2030 (USD Million)
    • 5.3.3 Dental Implants
      • 5.3.3.1 Global Dental Implants Market, 2018 - 2030 (USD Million)
    • 5.3.4 Bone Grafts & Substitutes
      • 5.3.4.1 Global Bone Graft & Substitutes Market, 2018 - 2030 (USD Million)
    • 5.3.5 Dental Membranes
      • 5.3.5.1 Global Dental Membranes Market, 2018 - 2030 (USD Million)
    • 5.3.6 Dental Sutures
      • 5.3.6.1 Global Dental Sutures Market, 2018 - 2030 (USD Million)
    • 5.3.7 Others
      • 5.3.7.1 Global others market, 2018 - 2030 (USD Million)
  • 5.4 Plastic Surgery
    • 5.4.1 Global Plastic Surgery Market, 2018 - 2030 (USD Million)
    • 5.4.2 Facial Wrinkle Treatment
      • 5.4.2.1 Global Facial Wrinkle Treatment Market, 2018 - 2030 (USD Million)
    • 5.4.3 Soft Tissue Fillers
      • 5.4.3.1 Global Soft Tissue Fillers Market, 2018 - 2030 (USD Million)
    • 5.4.4 Craniofacial Surgery
      • 5.4.4.1 Global Craniofacial Surgery Market, 2018 - 2030 (USD Million)
      • 5.4.4.2 Sutures
      • 5.4.4.2.1 Global Sutures Market, 2018 - 2030 (USD Million)
      • 5.4.4.3 Others
      • 5.4.4.3.1 Others Market, 2018 - 2030 (USD Million)
    • 5.4.5 Bioengineered Skins
      • 5.4.5.1 Global Bioengineered Skins Market, 2018 - 2030 (USD Million)
    • 5.4.6 Peripheral Nerve Repair
      • 5.4.6.1 Global Peripheral Nerve Repair Market, 2018 - 2030 (USD Million)
    • 5.4.7 Acellular Dermal Matrices
      • 5.4.7.1 Global Acellular Dermal Matrices Market, 2018 - 2030 (USD Million)
    • 5.4.8 Others
      • 5.4.8.1 Global others market, 2018 - 2030 (USD Million)
  • 5.5 Neurology
    • 5.5.1 Global Neurology Market, 2018 - 2030 (USD Million)
    • 5.5.2 Neural Stem Cell Encapsulation
      • 5.5.2.1 Global Neural Stem Cell Encapsulation Market, 2018 - 2030 (USD Million)
    • 5.5.3 Shunting Systems
      • 5.5.3.1 Global Shunting Systems Market, 2018 - 2030 (USD Million)
    • 5.5.4 Hydrogel Scaffold
      • 5.5.4.1 Global Hydrogel Scaffold Market, 2018 - 2030 (USD Million)
    • 5.5.5 Cortical Neural Prosthetics
      • 5.5.5.1 Global Cortical Neural Prosthetics Market, 2018 - 2030 (USD Million)
    • 5.5.6 Others
      • 5.5.6.1 Global others market, 2018 - 2030 (USD Million)
  • 5.6 Orthopedic
    • 5.6.1 Global Orthopedic Market, 2018 - 2030 (USD Million)
    • 5.6.2 Joint Replacement Polymeric Biomaterials
      • 5.6.2.1 Global Joint Replacement Biomaterials Market, 2018 - 2030 (USD Million)
    • 5.6.3 Tissue Fixation Products
      • 5.6.3.1 Global Tissue Fixation Products Market, 2018 - 2030 (USD Million)
      • 5.6.3.2 Sutures
      • 5.6.3.2.1 Global Sutures Market, 2018 - 2030 (USD Million)
      • 5.6.3.3 Other
      • 5.6.3.3.1 Global Other Market, 2018 - 2030 (USD Million)
    • 5.6.4 Orthobiologics
      • 5.6.4.1 Global Orthobiologics Market, 2018 - 2030 (USD Million)
    • 5.6.5 Viscosupplementation
      • 5.6.5.1 Global Viscosupplementation Market, 2018 - 2030 (USD Million)
    • 5.6.6 Spine Biomaterials
      • 5.6.6.1 Global Spine Biomaterials Market, 2018 - 2030 (USD Million)
    • 5.6.7 Others
      • 5.6.7.1 Global others market, 2018 - 2030 (USD Million)
  • 5.7 Other Application
    • 5.7.1 Global Other Applications Market, 2018 - 2030 (USD Million)

Chapter 6 Regional Business Analysis

  • 6.1 North America
    • 6.1.1 North America Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.1.2 U.S.
      • 6.1.2.1 Key country dynamics
      • 6.1.2.2 U.S. polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.1.2.3 Market scenario
      • 6.1.2.4 Regulatory framework
      • 6.1.2.5 Disease prevalence
    • 6.1.3 Canada
      • 6.1.3.1 Key country dynamics
      • 6.1.3.2 Canada polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.1.3.3 Market scenario
      • 6.1.3.4 Regulatory framework
      • 6.1.3.5 Disease prevelance
  • 6.2 Europe
    • 6.2.1 Europe Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2 Germany
      • 6.2.2.1 Key country dynamics
      • 6.2.2.2 Germany polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.2.2.3 Market scenario
      • 6.2.2.4 Regulatory framework
      • 6.2.2.5 Disease prevelance
    • 6.2.3 UK
      • 6.2.3.1 Key country dynamics
      • 6.2.3.2 UK polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.2.3.3 Market scenario
      • 6.2.3.4 Regulatory framework
      • 6.2.3.5 Disease Prevelance
    • 6.2.4 France
      • 6.2.4.1 Key Country Dynamics
      • 6.2.4.2 France Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 6.2.4.3 Market Scenario
      • 6.2.4.4 Regulatory Framework
      • 6.2.4.5 Disease Prevalence
    • 6.2.5 Italy
      • 6.2.5.1 Key country dynamics
      • 6.2.5.2 Italy polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.2.5.3 Market scenario
      • 6.2.5.4 Regulatory framework
      • 6.2.5.5 Disease prevelance
    • 6.2.6 Spain
      • 6.2.6.1 Key country dynamics
      • 6.2.6.2 Spain polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.2.6.3 Market scenario
      • 6.2.6.4 Regulatory framework
      • 6.2.6.5 Disease prevelance
    • 6.2.7 Denmark
      • 6.2.7.1 Key Country Dynamics
      • 6.2.7.2 Denmark Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 6.2.7.3 Market Scenario
      • 6.2.7.4 Regulatory Framework
      • 6.2.7.5 Disease Prevelance
    • 6.2.8 Sweden
      • 6.2.8.1 Key Country Dynamics
      • 6.2.8.2 Sweden Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 6.2.8.3 Market Overview
      • 6.2.8.4 Regulatory Framework
      • 6.2.8.5 Disease Prevelance
    • 6.2.9 Norway
      • 6.2.9.1 Key country dynamics
      • 6.2.9.2 Norway polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.2.9.3 Market scenario
      • 6.2.9.4 Regulatory framework
      • 6.2.9.5 Disease prevelance
  • 6.3 Asia Pacific
    • 6.3.1 Asia Pacific Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2 JAPAN
      • 6.3.2.1 Key country dynamics
      • 6.3.2.2 Japan polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.3.2.3 Market overview
      • 6.3.2.4 Regulatory framework
      • 6.3.2.5 Disease prevelance
    • 6.3.3 China
      • 6.3.3.1 Key Country Dynamics
      • 6.3.3.2 China Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 6.3.3.3 Market Scenario
      • 6.3.3.4 Regulatory Framework
      • 6.3.3.5 Disease Prevelance
    • 6.3.4 India
      • 6.3.4.1 Key country dynamics
      • 6.3.4.2 India polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.3.4.3 Market scenario
      • 6.3.4.4 Regulatory framework
      • 6.3.4.5 Disease prevelance
    • 6.3.5 Australia
      • 6.3.5.1 Key Country Dynamics
      • 6.3.5.2 Australia Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 6.3.5.3 Market Scenario
      • 6.3.5.4 Regulatory Framework
      • 6.3.5.5 Disease Prevelance
    • 6.3.6 Thailand
      • 6.3.6.1 Key country dynamics
      • 6.3.6.2 Thailand polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.3.6.3 Market Scenario
      • 6.3.6.4 Regulatory Framework
      • 6.3.6.5 Disease Prevelance
    • 6.3.7 South Korea
      • 6.3.7.1 Key Country Dynamics
      • 6.3.7.2 South Korea Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 6.3.7.3 Market scenario
      • 6.3.7.4 Regulatory framework
      • 6.3.7.5 Disease prevelance
  • 6.4 Latin America
    • 6.4.1 Latin America Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2 Brazil
      • 6.4.2.1 Key country dynamics
      • 6.4.2.2 Brazil polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.4.2.3 Market scenario
      • 6.4.2.4 Regulatory framework
      • 6.4.2.5 Disease prevelance
    • 6.4.3 Mexico
      • 6.4.3.1 Key Country Dynamics
      • 6.4.3.2 Mexico Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 6.4.3.3 Market Scenario
      • 6.4.3.4 Regulatory Framework
      • 6.4.3.5 Disease Prevelance
    • 6.4.4 Argentina
      • 6.4.4.1 Key country dynamics
      • 6.4.4.2 Argentina polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.4.4.3 Market scenario
      • 6.4.4.4 Regulatory framework
      • 6.4.4.5 Disease prevelance
  • 6.5 MEA
    • 6.5.1 MEA Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2 South Africa
      • 6.5.2.1 Key Country Dynamics
      • 6.5.2.2 South Africa Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 6.5.2.3 Market Scenario
      • 6.5.2.4 Regulatory Framework
      • 6.5.2.5 Disease Prevelance
    • 6.5.3 Saudi Arabia
      • 6.5.3.1 Key country dynamics
      • 6.5.3.2 Saudi Arabia polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.5.3.3 Market scenario
      • 6.5.3.4 Regulatory framework
      • 6.5.3.5 Disease prevelance
    • 6.5.4 UAE
      • 6.5.4.1 Key country dynamics
      • 6.5.4.2 UAE polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.5.4.3 Market scenario
      • 6.5.4.4 Regulatory framework
      • 6.5.4.5 Disease prevelance
    • 6.5.5 Kuwait
      • 6.5.5.1 Key country dynamics
      • 6.5.5.2 Kuwait polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.5.5.3 Market scenario
      • 6.5.5.4 Regulatory framework
      • 6.5.5.5 Disease prevelance

Chapter 7 Competitive Landscape

  • 7.1 Participant's Overview
    • 7.1.1 MEDTRONIC
      • 7.1.1.1 Overview
      • 7.1.1.2 Financial Performance
      • 7.1.1.3 Product Benchmarking
      • 7.1.1.4 Strategic Initiatives
    • 7.1.2 STRYKER CORPORATION
      • 7.1.2.1 Overview
      • 7.1.2.2 Financial Performance
      • 7.1.2.3 Product Benchmarking
      • 7.1.2.4 Strategic Initiatives
    • 7.1.3 BASF SE
      • 7.1.3.1 Overview
      • 7.1.3.2 Financial Performance
      • 7.1.3.3 Product Benchmarking
      • 7.1.3.4 Strategic Initiatives
    • 7.1.4 EVONIK INDUSTRIES AG
      • 7.1.4.1 Overview
      • 7.1.4.2 Financial Performance
      • 7.1.4.3 Product Benchmarking
      • 7.1.4.4 Strategic Initiatives
    • 7.1.5 DSM
      • 7.1.5.1 Overview
      • 7.1.5.2 Financial Performance
      • 7.1.5.3 Product Benchmarking
      • 7.1.5.4 Strategic Initiatives
    • 7.1.6 BEZWADA BIOMEDICAL, LLC
      • 7.1.6.1 Overview
      • 7.1.6.2 Product Benchmarking
      • 7.1.6.3 Strategic Initiatives
    • 7.1.7 CORBION
      • 7.1.7.1 Overview
      • 7.1.7.2 Financial Performance
      • 7.1.7.3 Product Benchmarking
      • 7.1.7.4 Strategic Initiatives
    • 7.1.8 VICTREX PLC (INVIBIO LTD.)
      • 7.1.8.1 Overview
      • 7.1.8.2 Financial Performance
      • 7.1.8.3 Product Benchmarking
      • 7.1.8.4 Strategic Initiatives
    • 7.1.9 INTERNATIONAL POLYMER ENGINEERING
      • 7.1.9.1 Overview
      • 7.1.9.2 Product Benchmarking
      • 7.1.9.3 Strategic Initiatives
    • 7.1.10 COVALON TECHNOLOGIES LTD.
      • 7.1.10.1 Overview
      • 7.1.10.2 Financial Performance
      • 7.1.10.3 Product Benchmarking
      • 7.1.10.4 Strategic Initiatives
    • 7.1.11 ABBOTT
      • 7.1.11.1 Overview
      • 7.1.11.2 Financial Performance
      • 7.1.11.3 Product Benchmarking
      • 7.1.11.4 Strategic Initiatives
    • 7.1.12 ELIXIR MEDICAL
      • 7.1.12.1 Overview
      • 7.1.12.2 Product Benchmarking
      • 7.1.12.3 Strategic Initiatives
    • 7.1.13 REVA MEDICAL, LLC
      • 7.1.13.1 Overview
      • 7.1.13.2 Product Benchmarking
      • 7.1.13.3 Strategic Initiatives
    • 7.1.14 MERIL LIFE SCIENCES PVT. LTD.
      • 7.1.14.1 Overview
      • 7.1.14.2 Product Benchmarking
      • 7.1.14.3 Strategic Initiatives
    • 7.1.15 MICROPORT SCIENTIFIC CORPORATION
      • 7.1.15.1 Overview
      • 7.1.15.2 Financial Performance
      • 7.1.15.3 Product Benchmarking
      • 7.1.15.4 Strategic Initiatives
  • 7.2 Participant Categorization
    • 7.2.1 Polymeric Biomaterials Market Share Analysis, 2023
  • 7.3 Strategy Mapping
    • 7.3.1 Expansion
    • 7.3.2 Acquisition
    • 7.3.3 Collaborations & Partnerships
    • 7.3.4 Product Launch
    • 7.3.5 Others

Chapter 8 Analyst View

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global polymeric biomaterials market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America polymeric biomaterials market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 10 Canada polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 12 Europe polymeric biomaterials market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 15 Germany polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 16 Germany polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 17 UK polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 18 UK polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 19 France polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 20 France polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 21 Italy polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 22 Italy polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 23 Spain polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 24 Spain polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 25 Denmark polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 26 Denmark polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 27 Sweden polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 28 Sweden polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 29 Norway polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 30 Norway polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific polymeric biomaterials market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 34 China polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 35 China polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 36 Japan polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 37 Japan polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 38 India polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 39 India polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 40 South Korea polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 41 South Korea polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 42 Australia polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 43 Australia polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 44 Thailand polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 45 Thailand polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 46 Latin America polymeric biomaterials market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 48 Latin America polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 49 Brazil polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 50 Brazil polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 51 Mexico polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 52 Mexico polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 53 Argentina polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 57 South Africa polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 58 South Africa polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 61 UAE polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 62 UAE polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
  • Table 63 Kuwait polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
  • Table 64 Kuwait polymeric biomaterials market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Polymeric biomaterials market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research application
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modeling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Biomaterials market value, 2023 (USD Billion)
  • Fig. 16 Market trends & outlook
  • Fig. 17 PESTEL analysis
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 Polymeric biomaterials market: Product outlook key takeaways
  • Fig. 20 Polymeric biomaterials market: Product movement analysis
  • Fig. 21 Global Polylactic Acid (PLA) market, 2018 - 2030 (USD Million)
  • Fig. 22 Global Polyglycolic Acid (PGA) market, 2018 - 2030 (USD Million)
  • Fig. 23 Global polyurethanes market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Polytetrafluoroethylene (PTFE) & expanded Polytetrafluoroethylene (ePTFE) market, 2018 - 2030 (USD Million)
  • Fig. 25 Global Polyaryletheretherketone (PEEK) market, 2018 - 2030 (USD Million)
  • Fig. 26 Global Polydioxanone (PDO) market, 2018 - 2030 (USD Million)
  • Fig. 27 Global other products market, 2018 - 2030 (USD Million)
  • Fig. 28 Polymeric biomaterials market: Application outlook and key takeaways
  • Fig. 29 Polymeric biomaterials market: Application movement analysis
  • Fig. 30 Global cardiovascular market, 2018 - 2030 (USD Million)
  • Fig. 31 Global bioresorbable stents market, 2018 - 2030 (USD Million)
  • Fig. 32 Global vascular grafts market, 2018 - 2030 (USD Million)
  • Fig. 33 Global sensors market, 2018 - 2030 (USD Million)
  • Fig. 34 Global guidewires market, 2018 - 2030 (USD Million)
  • Fig. 35 Global implantable cardiac defibrillators market, 2018 - 2030 (USD Million)
  • Fig. 36 Global pacemakers market, 2018 - 2030 (USD Million)
  • Fig. 37 Global others market, 2018 - 2030 (USD Million)
  • Fig. 38 Global dental market, 2018 - 2030 (USD Million)
  • Fig. 39 Global tissue regeneration market, 2018 - 2030 (USD Million)
  • Fig. 40 Global dental implants market, 2018 - 2030 (USD Million)
  • Fig. 41 Global bone graft & substitutes market, 2018 - 2030 (USD Million)
  • Fig. 42 Global dental membranes market, 2018 - 2030 (USD Million)
  • Fig. 43 Global dental sutures market, 2018 - 2030 (USD Million)
  • Fig. 44 Global others market, 2018 - 2030 (USD Million)
  • Fig. 45 Global plastic surgery market, 2018 - 2030 (USD Million)
  • Fig. 46 Global facial wrinkle treatment market, 2018 - 2030 (USD Million)
  • Fig. 47 Global soft tissue fillers market, 2018 - 2030 (USD Million)
  • Fig. 48 Global craniofacial surgery market, 2018 - 2030 (USD Million)
  • Fig. 49 Global sutures market, 2018 - 2030 (USD Million)
  • Fig. 50 Global others market, 2018 - 2030 (USD Million)
  • Fig. 51 Global bioengineered skins market, 2018 - 2030 (USD Million)
  • Fig. 52 Global peripheral nerve repair market, 2018 - 2030 (USD Million)
  • Fig. 53 Global acellular dermal matrices market, 2018 - 2030 (USD Million)
  • Fig. 54 Global others market, 2018 - 2030 (USD Million)
  • Fig. 55 Global neurology market, 2018 - 2030 (USD Million)
  • Fig. 56 Global neural stem cell encapsulation market, 2018 - 2030 (USD Million)
  • Fig. 57 Global shunting systems market, 2018 - 2030 (USD Million)
  • Fig. 58 Global hydrogel scaffold market, 2018 - 2030 (USD Million)
  • Fig. 59 Global cortical neural prosthetics, 2018 - 2030 (USD Million)
  • Fig. 60 Global others market, 2018 - 2030 (USD Million)
  • Fig. 61 Global orthopedic market, 2018 - 2030 (USD Million)
  • Fig. 62 Global joint replacement biomaterials market, 2018 - 2030 (USD Million)
  • Fig. 63 Global tissue fixation products market, 2018 - 2030 (USD Million)
  • Fig. 64 Global sutures market, 2018 - 2030 (USD Million)
  • Fig. 65 Global others market, 2018 - 2030 (USD Million)
  • Fig. 66 Global orthobiologics Market, 2018 - 2030 (USD Million)
  • Fig. 67 Global viscosupplementation market, 2018 - 2030 (USD Million)
  • Fig. 68 Global spine biomaterials market, 2018 - 2030 (USD Million)
  • Fig. 69 Global others market, 2018 - 2030 (USD Million)
  • Fig. 70 Global other applications market, 2018 - 2030 (USD Million)
  • Fig. 71 Regional marketplace: Key takeaways
  • Fig. 72 Regional marketplace: Key takeaways
  • Fig. 73 North America polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 U.S. polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 U.S. target disease prevalence
  • Fig. 77 Key country dynamics
  • Fig. 78 Canada polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Canada target disease prevalence
  • Fig. 80 Europe polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Germany polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Germany. target disease prevalence
  • Fig. 84 Key country dynamics
  • Fig. 85 UK polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 UK target disease prevalence
  • Fig. 87 Key country dynamics
  • Fig. 88 France polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 France target disease prevalence
  • Fig. 90 Key country dynamics
  • Fig. 91 Italy polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Italy target disease prevalence
  • Fig. 93 Key country dynamics
  • Fig. 94 Spain polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Spain target disease prevalence
  • Fig. 96 Key country dynamics
  • Fig. 97 Denmark polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Denmark target disease prevalence
  • Fig. 99 Key country dynamics
  • Fig. 100 Sweden polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Sweden target disease prevalence
  • Fig. 102 Key country dynamics
  • Fig. 103 Norway polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Norway target disease prevalence
  • Fig. 105 Asia Pacific polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 Japan polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108 Japan target disease prevalence
  • Fig. 109 Key country dynamics
  • Fig. 110 China polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 China target disease prevalence
  • Fig. 112 Key country dynamics
  • Fig. 113 India polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 114 India target disease prevalence
  • Fig. 115 Key country dynamics
  • Fig. 116 Australia polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 117 Australia target disease prevalence
  • Fig. 118 Key country dynamics
  • Fig. 119 Thailand polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 120 Key country dynamics
  • Fig. 121 South Korea polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 122 South Korea target disease prevalence
  • Fig. 123 Latin America polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 124 Key country dynamics
  • Fig. 125 Brazil polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 126 Brazil target disease prevalence
  • Fig. 127 Key country dynamics
  • Fig. 128 Mexico polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 129 Mexico target disease prevalence
  • Fig. 130 Key country dynamics
  • Fig. 131 Argentina polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 132 Argentina target disease prevalence
  • Fig. 133 MEA polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 134 Key country dynamics
  • Fig. 135 South Africa polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 136 South Africa target disease prevalence
  • Fig. 137 Key country dynamics
  • Fig. 138 Saudi Arabia polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 139 Saudi Arabia target disease prevalence
  • Fig. 140 Key country dynamics
  • Fig. 141 UAE polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 142 UAE target disease prevalence
  • Fig. 143 Key country dynamics
  • Fig. 144 Kuwait polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 145 Kuwait target disease prevalence
  • Fig. 146 Market participant categorization
  • Fig. 147 Polymeric biomaterials market share analysis, 2023
  • Fig. 148 Strategic framework